ArticleMolecular cancer therapeutics2021

Novel TGFβ Inhibitors Ameliorate Oral Squamous Cell Carcinoma Progression and Improve the Antitumor Immune Response of Anti-PD-L1 Immunotherapy.

Nils Ludwig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.